These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3430341)

  • 1. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
    Chung BH; Shim CK
    J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.
    el-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1985 Feb; 74(2):161-4. PubMed ID: 3989685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children.
    Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Merrick JG
    Drug Intell Clin Pharm; 1988 Sep; 22(9):684-7. PubMed ID: 3215109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
    Contreras J; Pérez N; González R; Ontivero E; López M
    Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media.
    Fassihi AR; Munday DL
    J Pharm Pharmacol; 1989 Jun; 41(6):369-72. PubMed ID: 2570830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Vashi VI; Hepp P; Hunt J
    Pharm Res; 1993 Jul; 10(7):1037-45. PubMed ID: 8378245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method.
    Ikegami K; Tagawa K; Kobayashi M; Osawa T
    Int J Pharm; 2003 Jun; 258(1-2):31-43. PubMed ID: 12753751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
    Yomota C; Miyazaki T; Okada S
    Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and evaluation of press-coated aminophylline tablet using crystalline cellulose and polyethylene glycol in the outer shell for timed-release dosage forms].
    Watanabe Y; Mukai B; Kawamura K; Ishikawa T; Namiki M; Utoguchi N; Fujii M
    Yakugaku Zasshi; 2002 Feb; 122(2):157-62. PubMed ID: 11857956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
    Lohmann A; Dingler E; Sommer W
    Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions.
    Steinijans VW; Schulz HU; Böhm A; Beier W
    Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
    Ikegami K; Tagawa K; Osawa T
    J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP; Meyer UA
    Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.